Task: Answer the multiple choice question.
Question: Which drug exhibits a 3.406\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
[a] CCOC(=O)c1cn(CC(=O)Nc2ccc(OC)cc2OC)nn1
[b] CC(Oc1cc2oc(=O)c3c(c2cc1Cl)CCCC3)C(=O)NCc1cccnc1
[c] COc1ccc2nc(NC(=O)CCN3C(=O)c4ccccc4C3=O)sc2c1
Answer: c. COc1ccc2nc(NC(=O)CCN3C(=O)c4ccccc4C3=O)sc2c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc2nc(NC(=O)CCN3C(=O)c4ccccc4C3=O)sc2c1
COc1ccc2nc(NC(=O)CCN3C(=O)c4ccccc4C3=O)sc2c1
3-(1,3-dioxoisoindol-2-yl)-N-(6-methoxy-1,3-benzothiazol-2-yl)propanamide